Role of tyrosine kinase on Ca2+ entry and refilling of agonist-sensitive Ca2+ stores in vascular smooth muscles

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 3, 1996, Pages 298-304

  Low, A M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Contraction; Dog mesenteric artery; Dog saphenous vein; Genistein; Tyrphostin

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; CARBACHOL; CYCLOPIAZONIC ACID; GENISTEIN; N(G) NITROARGININE METHYL ESTER; NICARDIPINE; PHENYLEPHRINE; PROTEIN TYROSINE KINASE; TYRPHOSTIN;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOG; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0029937445     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-021     Document Type: Article

References (25)

1. 2+ influx. Biochem. J. 274: 193-197.
2. DiSalvo, J., Steusloff, A., Semenchuk, L., Satoh, S., Kolquist, K., and Pfitzer, G. 1993. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190: 968-974.
3. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol. 15: 77-83.
4. 2+ entry in human platelets: a reply. Biochem. J. 285: 343-344.
5. Hollenberg, M.D. 1994. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. 15: 108-114.
6. 2+-dependent manner. Mol. Cell. Biol. 10: 6290-6298.
7. 2+-dependent increase in tyrosine kinase activity stimulated by angiotensin II. Proc. Natl. Acad. Sci. U.S.A. 89: 8837-8841.
8. Laniyonu, A.A., Saifeddine, M., Ahmad, S., and Hollenberg, M.D. 1994a. Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br. J. Pharmacol. 113: 403-410.
9. Laniyonu, A.A., Saifeddine, M., Yang, S.-G., and Hollenberg, M.D. 1994b. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists. Can. J. Physiol. Pharmacol. 72: 1075-1085.
10. 2+ entry by tyrosine kinase inhibitors. J. Biol. Chem. 268: 9945-9948.
11. 2+ stores in canine mesenteric artery with different refilling mechanisms. Am. J. Physiol. 262: H31-H37.
12. 2+-activated membrane currents in smooth muscle. Biol. Signals, 2: 263-271.
13. 2+ entry. Biochem. J. 271: 515-522.
14. 2+ influx. Nature (London), 364: 809-814.
15. 2+ store. Biochem. J. 265: 675-680.
16. 2+ entry in human platelets. Biochem. J. 285: 341-343.
17. Saifeddine, M., Laniyonu, A., Yang, S.-G., and Hollenberg, M.D. 1992. Tyrosine kinase inhibitors and the contractile action of angiotensin-II in vascular tissue. Pharmacol. Commun. 1: 177-184.
18. 2+ entry. Cell Calcium, 13: 553-564.
19. 2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J. Biol. Chem. 268: 18 151-18 156.
20. 2+-influx pathway. Biochem. J. 284: 521-530.
21. Thurston, A.W., Jr., Rhee, S.G., and Shukla, S.D. 1993. Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms. J. Pharmacol. Exp. Ther. 266: 1106-1112.
22. 2+ currents in rat ventricular myocytes. Br. J. Pharmacol. 109: 895-897.
23. 2+ influx by mechanisms other than cytochrome P-450 inhibition. Biochem. J. 295: 525-529.
24. 2+ antagonistically control tyrosine phosphorylation of specific platelet proteins. J. Biol. Chem. 266: 16 911-16 916.
25. 2+ channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189: 1620-1623.